Cancer Trials Ireland > Articles by: ICORG

ICORG

International Clinical Trials Day 2015

Every year International Clinical Trials Day is marked around the world on or near the May 20th to celebrate the day that James Lind began his controlled trial comparing the different treatments for scurvy on the 20th May 1747.

Thanks to James Lind, carefully regulated Clinical Trials are the most effective way to establish which new treatments are beneficial for patients and improve their outcomes. International Clinical Trials Day provides a focal point to raise awareness of the importance of clinical research.

With Research Comes Hope

 

Breast Cancer Test (OncotypeDX)

News released today shows Breast Cancer Test – OncotypeDX – reduces the need for Chemotherapy.

ICORG was involved in this Global Clinical Trial associated with the development of this; nearly 700 Irish Patients took part at Hospitals throughout Ireland between 2007 – 2010.

Dr Janice Walshe was the Chief Investigator in Ireland. Click for the related news pieces on : RTE News and newstalk

MTCI Immunotherapy Forum

On Friday 23rd January [4pm – 7pm] in the Herbert Park Hotel, Ballsbridge, Dublin 4, MTCI are hosting a Translational Research Forum on "Successful, Immunotherapeutic approaches to treat Adjuvant, Occult disease in Carcinoma". The Guest Speakers are Dr. Michael G. Hanna, Ph.D. & Dr. Jan Vermorken, M.D., Ph.D.

RsqVD - New ICORG Blood Cancer Study

RsqVD is a new Clinical Trial in Multiple Myeloma that ICORG is operating through 8 Hospital Centres throughout Ireland and in conjugation with the Dana Farber Institute.
 
Click here for recent press coverage or here for further trial details